Multi-Omics Blood Atlas Reveals Host Immune Response Features of Immunocompromised Populations Following SARS-CoV-2 Infection
Open Access
- 11 September 2025
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 24 (10) , 101068
Abstract
No abstract availableKeywords
Funding Information
- Peking University First Hospital (2022CR38)
- Beijing Natural Science Foundation
This publication has 70 references indexed in Scilit:
- Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysisReviews in Medical Virology, 2024
- A urinary proteomic landscape of COVID-19 progression identifies signaling pathways and therapeutic optionsScience China Life Sciences, 2022
- Identification of Required Host Factors for SARS-CoV-2 Infection in Human CellsCell, 2021
- Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 InfectionCell, 2021
- Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor NetworksCell, 2020
- Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19Cell, 2020
- SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host DefensesCell, 2020
- The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactionsProtein Science, 2020
- The Global Phosphorylation Landscape of SARS-CoV-2 InfectionCell, 2020
- ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ SecretionCell, 2017